During the past decade, Outpatient Clinic of Viral Hepatitis (NUPAIG) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Outpatient Clinic of Viral Hepatitis (NUPAIG)" are "Hepatitis C, Chronic" (2 trials), "Flaviviridae Infections" (1 trials), "Hepatitis C" (1 trials) and "RNA Virus Infections" (1 trials). Many other conditions were trialed in "Outpatient Clinic of Viral Hepatitis (NUPAIG)" in a lesser frequency.

Most popular intervention types in "Outpatient Clinic of Viral Hepatitis (NUPAIG)" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Daclatasvir + Sofosbuvir" (1 trials), "Simeprevir + Sofosbuvir" (1 trials), "Vitamin B 12" (1 trials) and "Vitamin D" (1 trials). Other intervention names were less common.

The vast majority of trials in "Outpatient Clinic of Viral Hepatitis (NUPAIG)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Outpatient Clinic of Viral Hepatitis (NUPAIG)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Outpatient Clinic of Viral Hepatitis (NUPAIG), undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Outpatient Clinic of Viral Hepatitis (NUPAIG), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".